SRV Hospital
Private Equity Round in 2025
SRV Hospital provides plastic surgery, psychiatry, pediatrics and neonatology, orthopedics, oncology, physiotherapy, neurology, nephrology, gynecology and obstetrics, general surgery-laparoscopy, gastroenterology, ent, dietetics, dermatology, pulmonary/respiratory medicine, and cardiology services.
Maiva Pharma
Private Equity Round in 2024
Maiva Pharma is a manufacturer of liquid sterile formulations, producing products in small-volume glass vials, ampoules, and large-volume glass bottles, based in Krishnagiri, Tamil Nadu; the company offers end-to-end pharmaceutical services including formulation and analytical methods development, product licensing, and nitrosamine risk assessment, in addition to manufacturing sterile vials.
Fleming Laboratories
Private Equity Round in 2023
Fleming Laboratories specializes in the development and manufacturing of generic active pharmaceutical ingredients (APIs) for the global pharmaceutical industry. They offer comprehensive services including process research and development, infrastructure management, manufacturing, quality control, regulatory affairs, and environmental safety management.
ABI Health
Private Equity Round in 2023
ABI Health is a healthcare technology company that specializes in health exchange and image management cloud software solutions. Founded in 2013 and headquartered in Bengaluru, India, with additional offices in the United States and Peru, the company offers a comprehensive healthcare platform designed to enhance patient engagement and facilitate collaboration among healthcare providers. Its product suite includes advanced diagnostic imaging tools, such as the Spectra imaging suite, which connects hospitals, laboratories, medical clinics, doctors, and patients. ABI Health also develops clinical applications, mobile applications, cloud solutions, and patient portals, while providing healthcare consulting services focused on interoperability and technology integration. By leveraging data science and analytics, ABI Health aims to improve patient care and streamline healthcare operations, ensuring that healthcare professionals can access vital patient data efficiently from any location.
Pregna International
Private Equity Round in 2023
Pregna International is a manufacturer of contraceptive devices designed to empower women to lead a stress‑free life. The company produces a range of products, including cryopop, eloira, esa, pregna copper, and etherena, which help women prevent unwanted pregnancies.
Sunways
Private Equity Round in 2022
Sunways is a pharmaceutical company that specializes in the manufacture and marketing of a diverse range of formulations, primarily in the fields of ophthalmology and ear, nose, and throat (ENT) care. The company produces medicines aimed at treating eye-related diseases and conditions, offering products such as antibiotics, antioxidants, vitreoretinal protectors, as well as treatments for glaucoma and cataracts. These products are developed under the technical supervision of industry experts, ensuring high standards of production and quality assurance. Sunways is committed to providing sterile ophthalmic and ENT products to meet the needs of healthcare professionals and patients.
Accumax
Private Equity Round in 2022
Accumax is a manufacturer of liquid handling products and lab consumables, primarily serving the clinical, biotechnology, molecular biology, life science, pharmaceutical, and biopharmaceutical sectors. The company offers a diverse range of products, including pipettes, dispensers, controllers, pipette tips, centrifuge tubes, PCR consumables, and deep well plates. Accumax focuses on delivering precision and ease of use in laboratory settings, ensuring that researchers have reliable tools to support their work.
Malladi Drugs & Pharmaceuticals
Private Equity Round in 2022
Malladi Drugs & Pharmaceuticals, established in 1980 and headquartered in Chennai, India, is a prominent pharmaceutical company. It specializes in the manufacturing of active pharmaceutical ingredients (APIs) for various therapeutic segments, with a significant focus on the cough and cold category. Additionally, the company produces APIs for anti-histamines, anti-convulsants, anti-depressants, and anxiolytics. Malladi offers contract manufacturing, custom synthesis, and contract research services, contributing to the global pharmaceutical industry. Its products are marketed and sold both in India and internationally, with a manufacturing facility also located in Carlstadt, New Jersey.
MediBuddy
Series C in 2022
MediBuddy is a digital healthcare platform that facilitates access to various services such as online doctor consultations, lab tests, and medicine delivery. Its mission is to make quality healthcare accessible and affordable for everyone, anytime, anywhere.
MediBuddy
Series B in 2021
MediBuddy is a digital healthcare platform that facilitates access to various services such as online doctor consultations, lab tests, and medicine delivery. Its mission is to make quality healthcare accessible and affordable for everyone, anytime, anywhere.
Inventia Healthcare
Private Equity Round in 2020
Inventia Healthcare Limited is a Mumbai-based pharmaceutical company that specializes in the development, manufacture, and sale of a range of oral solid dosage forms, including tablets, capsules, DC granules, and pellets. Founded in 1985, the company focuses on creating novel drug delivery systems based on single ingredients and unique combination products. Its product portfolio spans various therapeutic areas, including anti-diabetic, gastrointestinal, cardiovascular, central nervous system, pain management, urinogenital, anti-infective, respiratory, and musculoskeletal segments. In addition to serving the Indian market, Inventia Healthcare exports its products to multiple regions, including North America, Latin America, Europe, and various countries in Asia and Africa. The company's research and development center supports formulation development projects and provides contract research and manufacturing services to numerous domestic and international pharmaceutical companies.
Murli Krishna Pharma
Private Equity Round in 2020
Murli Krishna Pharma Private Limited is an Indian company based in Pune, established in 2004, that specializes in the development and manufacturing of advanced drug delivery systems. The company focuses on creating pellets, micro-pellets, and granules utilizing aqueous-based technology. Its product portfolio includes a variety of pharmaceutical formulations such as azithromycin mups and granules, budesonide nano pellets, clarithromycin mups and granules, and dex rabeprazole pellets, among others. Murli Krishna Pharma is recognized for its commitment to quality, with its manufacturing facility compliant with Good Manufacturing Practices as approved by the World Health Organization and the European Union. The company also undertakes formulation development projects, catering to the needs of pharmaceutical companies seeking optimized delivery solutions.
Sharp Sight Eye Hospitals
Private Equity Round in 2020
Sharp Sight Laser Centre Private Limited is a New Delhi-based network of eye care clinics established in 1998, specializing in comprehensive and affordable ophthalmology services across North India. The organization provides a wide range of services, including eye testing, cataract surgery, treatments for glaucoma and retinal conditions, as well as services for cornea, pediatric eye issues, and orbit disorders. By focusing on high-quality care, Sharp Sight aims to effectively address various eye care disorders, ensuring accessible and modern treatment options for its patients.
Ankura Hospital
Private Equity Round in 2019
Ankura Hospitals is a healthcare provider based in Hyderabad, India, specializing in services for women and children. Founded in 2011, the hospital chain offers a range of gynecological services, including obstetrics, painless delivery, and infertility treatment. For pediatric care, Ankura Hospitals provides general pediatrics, neonatal intensive care, pediatric intensive care, and specialized services such as pediatric neurology and gastroenterology. The organization is committed to delivering quality healthcare in a safe and supportive environment for its patients.
Intron Life Sciences
Private Equity Round in 2019
Intron Life Sciences Private Limited is a biotechnology company based in Hyderabad, India, established in 2018. It specializes in the manufacture of probiotic products aimed primarily at the poultry and aquaculture industries. The company offers a diverse range of products, including lactomax gold, rapigrow, and toxoff for poultry, as well as digimax and pondfresh for aquaculture applications. In addition to its standard offerings, Intron Life Sciences provides custom-made probiotic solutions tailored for the food industry and other sectors. The company's commitment to quality and innovation focuses on developing sustainable alternatives for animal health and environmentally friendly farming practices. Through its expertise in probiotics and related biotech products, Intron Life Sciences aims to enhance animal and habitat health while promoting sustainable agricultural practices.
Symbiotec Pharmalab
Private Equity Round in 2018
Symbiotec Pharmalab Ltd. is a manufacturer and exporter of research-based active pharmaceutical ingredients (APIs) specializing in corticosteroids and steroid hormones. Established in 1995 and located in Indore, Central India, the company is certified by WHO-GMP and ISO 9000:2000, underscoring its commitment to quality and compliance. Symbiotec leverages advanced technology to enhance the production of life-saving APIs, aiming to meet the global demand for corticosteroids while maintaining cost-competitive pricing. The company is dedicated to advancing healthcare by providing essential pharmaceutical ingredients that contribute to improved patient outcomes.
SymbioTec
Private Equity Round in 2018
SymbioTec AG is an engineering company based in Zurich, Switzerland, specializing in cabling systems for L1+ and FTTH infrastructure projects. Established in 2008, it provides enterprise cabling solutions and designs all passive elements for data centers. The company serves a diverse clientele, including notable organizations such as Johnson & Johnson, EWZ, R&M, Sunrise, and Stadtwerke Dusseldorf AG. Since 2009, SymbioTec has operated as a subsidiary of Beacon Enterprise Solutions Group, Inc.
Strides Pharma Science
Private Equity Round in 2018
Strides Pharma Science is a global pharmaceutical company headquartered in Bangalore, India. It develops, manufactures, and sells a wide range of pharmaceutical products, including generics, branded generics, and drugs for infectious diseases. The company operates two business verticals: Regulated Markets and Emerging Markets, serving customers across 100 countries with a global manufacturing footprint spanning four continents.
Aizant is a contract research organization specializing in integrated drug development solutions. It offers services including preformulation, formulation development for conventional and novel drugs, analytical development, cGMP scale-up, commercial manufacturing, bioavailability studies, bioequivalence testing, dosage form development, clinical research, project management, bioanalytical development, pharmacokinetics, biostatistics, and clinical diagnostics.
Oliva Clinic
Series A in 2017
Oliva Clinic operates a network of medico-aesthetic clinics that specialize in advanced skin and hair treatment services. The clinics are staffed by qualified cosmetic dermatologists, trichologists, and skin and hair therapists, ensuring comprehensive medical assessments and personalized treatment plans tailored to individual needs. By leveraging the latest advancements in medicine, Oliva Clinic aims to enhance the beauty and youthfulness of its patients. The facilities are equipped with modern healthcare equipment, allowing for a thorough analysis of skin and overall medical conditions before recommending appropriate treatments.
Stericon Pharma
Private Equity Round in 2016
Stericon Pharma is a manufacturer specializing in sterile multipurpose contact lens cleaning solutions and sterile formulations for eye and nasal applications. The company offers contract manufacturing services for sterile eye and ear drops, catering to the needs of pharmaceutical companies and exporters. With over 200 drug licenses, Stericon is equipped to meet diverse client requirements, allowing for the acquisition of additional licenses as necessary. Additionally, Stericon provides specialized manufacturing and packaging services for AYUSH products, which encompass Ayurveda, Yoga, Naturopathy, Unani, Siddha, and Homoeopathy. This focus on customized solutions enables Stericon Pharma to effectively serve retail businesses and enhance their product offerings in the eye care sector.
Biorad Medisys
Private Equity Round in 2016
Biorad Medisys is a manufacturer of surgical devices and related equipment, specializing in various medical fields including urology, gastroenterology, orthopedic implants, interventional radiology, gynecology, and vascular access. The company produces a range of products such as knee prostheses and other medical devices designed to meet the needs of patients and healthcare providers. By focusing on innovative solutions in these areas, Biorad Medisys aims to enhance patient care and improve clinical outcomes.
Sandor Medicaids Pvt. Ltd. is a nationwide distribution company specializing in supplies to hospitals and government institutions. It has developed efficient systems and capabilities to supply specialty drugs, device and equipment to hospitals. Since its inception in 1995 in Hyderabad, the company has focused on bringing high-tech biomedical and biotechnology products into India. Sandor has been the first company to bring “Point of Care” concept to the Indian ICU in 1996 by launch of i-stat, a state of the art product for emergency monitoring of patients.
The company started as a sales, marketing and distribution company and over time evolved as a nationwide distribution, sales and marketing company by 2008 when Genzyme launched their operations in India. It can today boast of a national level distribution network with 21CFR compliant cold chain facilities covering most of Indian states. Our efficient and compliant 20 branch distribution network supports drug and device manufacturers launch products with ready access to more than 3000 hospitals across India. The company today has more than 180 vendor registrations in Government and private Institutions making it the only partner for foreign or domestic manufacturers to bring their products to hospitals at the most economical costs while maintaining the highest ethical standards.
The company has over time developed a strong sales and marketing team which is helping it launch own branded products in select therapeutic area like Critical Care, Nephrology and Transplantation and Pain Management. Our strong presence in Government Institutions has ensured direct sales to all users without help of any sub dealer or liaison agents. The company also provides complete regulatory support to partners and has in-house pharmacovigilance function besides having a strong custom clearing department.
A firm foothold in the Indian Hospital procurement system has made Sandor a partner of choice for any new launch of medical drugs, devices and equipment in the Indian Hospital System.
Synergia Life Sciences
Private Equity Round in 2015
Synergia Life Sciences is a Mumbai-based manufacturer specializing in chemicals, pharmaceuticals, and botanical products, with a particular focus on vitamins. The company produces natural vitamins, including K2-7 (MenaquinGold), and probiotics, utilizing exclusively licensed technology and patents. These products are backed by comprehensive process and application patents, validated analytical methods, and data on stability, safety, and efficacy. Through its innovative offerings, Synergia Life Sciences aims to promote healthier hearts and bones for consumers.
Comprehensive Prosthetics & Orthotics
Private Equity Round in 2015
This company specializes in manufacturing and distributing high-quality prosthetics and orthotics products. They cater to both adult and pediatric markets across the Midwest region, focusing on artificial limbs and other custom-fabricated devices that prioritize patient comfort, mobility, and functionality.
Oliva Clinic
Series A in 2014
Oliva Clinic operates a network of medico-aesthetic clinics that specialize in advanced skin and hair treatment services. The clinics are staffed by qualified cosmetic dermatologists, trichologists, and skin and hair therapists, ensuring comprehensive medical assessments and personalized treatment plans tailored to individual needs. By leveraging the latest advancements in medicine, Oliva Clinic aims to enhance the beauty and youthfulness of its patients. The facilities are equipped with modern healthcare equipment, allowing for a thorough analysis of skin and overall medical conditions before recommending appropriate treatments.
Neuland Laboratories
Private Equity Round in 2012
Founded in 1984, Neuland Laboratories is a Hyderabad-based company that manufactures active pharmaceutical ingredients (APIs) for various therapeutic areas. It offers custom manufacturing solutions and peptide synthesis services, serving clients worldwide with no-compromise quality and a guarantee not to compete in finished products.
Anjan Drug
Private Equity Round in 2009
Anjan Drug is a manufacturer specializing in unique Active Pharmaceutical Ingredients (APIs) for the pharmaceutical industry. The company produces a range of products, including valproic acid, divalproex sodium, magnesium valproate, clorsulon, and pregabalin. Anjan Drug adheres to Good Manufacturing Practice (GMP) guidelines and has obtained approvals from regulatory authorities such as the US FDA, TGA, and EuCOS. This compliance ensures that clients receive high-quality ingredients at an efficient cost, supporting their drug development needs.
HealthCare Global
Private Equity Round in 2007
HealthCare Global Enterprises Ltd, headquartered in Bangalore, India, is recognized as a leading specialist in cancer care, operating a dedicated network of 20 centers. The organization provides comprehensive and quality cancer treatment, serving approximately 35,000 new patients annually. With a focus on advanced, complicated, and recurrent cancers, HealthCare Global has established a strong reputation both nationally and internationally. The organization's commitment to excellence in oncology was acknowledged with accolades for being a leader in the field in consecutive years, specifically during 2011 and 2012, when it received recognition in the Indian Health Care Awards.